Monographie - Enoxaparin sodium

Seneste opdatering :
08/05/2024

Enoxaparin sodium

Kemisk struktur

Handelsnavn

Handel navne er vejledende og hjælpestoffer sammensætning kan være forskellig afhængigt af landet og laboratorier

Bolentax	Mexico
Clasina	Colombia
Clenox	Colombia, Marokko
Clexan	Grækenland
Clexane	Argentina, Australien, Belgien, Brasilien, Chile, Colombia, Forenede Arabiske Emirater, Holland, Iran, Irland, Japan, Kroatien, Luxemborg, Marokko, Mexico, New Zealand, Polen, Rumænien, Saudi-Arabien, Schweiz, Spanien, Storbritanien, Sydafrika, Tyrkiet, Tyskland, Venezuela, Ægypten
Cutenox	Marokko
Dilutol	Argentina, Ecuador
Dynalin	Indien
Enoparin	Venezuela
Enoxalon	Chile
Enoxanorth	Argentina
Enoxatal	Colombia
Hemofagin	Chile
Heptron	Brasilien
Inhixa	Tyskland
Klexane	Danmark, Finland, Norge, Sverige
Lorapine	Argentina
Lovenox	Canada, Frankrig, USA, Østrig
Lowparin	Colombia
Nurox	Chile

Bibliografi : Enoxaparin sodium

	Type	Offentliggørelse
311	Journal	Newborn AL, Kessler JM, Joyner KA. Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours. Am J Health-Syst Pharm 1996 ; 53: 167-169.
811	Journal	Charland SL, Davis DD, Tillman DJ. Activity of enoxaparin sodium in tuberculin syringes for 10 days. Am J Health-Syst Pharm 1998 ; 55: 1296-1298.
1893	Journal	Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC. Anti-Xa stability of diluted enoxaparin for use in pediatrics. Ann Pharmacotherapy 2004 ; 38: 569-573.
2231	Journal	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3643	Laboratorium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
4413	Journal	Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J. Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution. J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.

Mentions Légales